TABLE 5.
Groups | Factors |
SC/ASC |
AC |
||
P | HR (95% CI) | P | HR (95% CI) | ||
Differentiated degree | Well/moderately/poorly | 0.005 | 1.815(1.198−2.750) | 0.002 | 1.514(1.158−1.981) |
Tumor size | ≤3 cm/>3 cm | 0.030 | 1.974(1.067−3.653) | 0.016 | 1.772(1.111−2.825) |
Gallstone | No/Yes | 0.461 | 1.237(0.702−2.180) | 0.460 | 1.153(0.791−1.679) |
TNM stage | I + II/III + IV | 0.024 | 3.662(1.189−11.280) | 0.002 | 2.965(1.499−5.865) |
Lymph node metastasis | No/Yes | 0.002 | 3.823(1.607−9.091) | 0.000 | 3.869(2.062−7.258) |
Invasion | No/Yes | 0.016 | 3.684(1.273−10.658) | 0.000 | 6.488(3.287−12.809) |
Surgery | Radical/Palliative/Biopsy | 0.016 | 1.960(1.132−3.393) | 0.000 | 2.284(1.522−3.427) |
XRCC1 | −/+ | 0.020 | 1.998(1.116−3.576) | 0.011 | 1.721(1.134−2.613) |
HR, hazard risk ratio; CI, confidence interval; −, negative expression; +, positive expression.